D311 Microbiology - Set 3 - Part 2
Test your knowledge of technical writing concepts with these practice questions. Each question includes detailed explanations to help you understand the correct answers.
Question 21: A physician prescribes an antibiotic for a patient with a confirmed Staphylococcus aureus skin infection. The drug works by preventing bacteria from building their protective outer layer, causing them to burst when exposed to osmotic pressure changes in the surrounding environment. Which mode of action applies?
Question 22: A patient develops a urinary tract infection caused by gram-negative bacteria. The physician selects a drug that specifically interferes with bacterial DNA replication machinery, preventing the organisms from copying their genetic material and reproducing within the urinary tract environment. Which mode of action applies?
Question 23: A clinician must choose between two antibiotics for a patient with an unknown infection. One kills a wide variety of bacterial species including normal flora, while the other targets only specific bacterial groups and preserves most beneficial microorganisms in the body. Which term describes the targeted drug?
Question 24: A patient recovering from a prolonged broad-spectrum antibiotic course develops a new intestinal infection caused by Clostridioides difficile overgrowth. The original antibiotic destroyed normal gut flora, allowing this opportunistic pathogen to flourish unchecked in the digestive tract. Which complication occurred?
Question 25: A pharmacist explains that a particular antibiotic works by mimicking a substrate needed for folic acid production in bacteria. The drug competes with the real substrate, blocking a metabolic pathway essential for bacterial survival while leaving human cells unaffected. Which mode of action applies?
Question 26: A hospital infection control team discovers that bacteria from a wound culture are no longer responding to the antibiotic originally prescribed. Lab results show the organisms now produce enzymes that chemically alter the drug before it can reach its bacterial target. Which resistance mechanism is demonstrated?
Question 27: A patient hospitalized for surgery develops a wound infection that does not respond to standard first-line antibiotics targeting cell wall synthesis. Culture results confirm the organism is Staphylococcus aureus with an altered penicillin-binding protein that blocks methicillin from attaching. Which resistant organism is identified?
Question 28: A microbiologist studying antibiotic resistance finds that certain bacteria survive tetracycline treatment by using specialized membrane transport proteins. These proteins actively pump the antibiotic out of the bacterial cell before it can accumulate enough to inhibit protein synthesis effectively. Which mechanism is described?
Question 29: A laboratory discovers that bacteria resistant to one specific antibiotic are automatically resistant to several chemically similar drugs the patient has never been exposed to before. This shared resistance among related drug classes complicates treatment planning for the infection significantly. Which concept does this illustrate?
Question 30: An immunocompromised patient in intensive care develops an infection caused by Enterococcus species that testing confirms cannot be treated with the antibiotic typically reserved as a last resort for serious gram-positive infections. The organism has modified its cell wall target site. Which resistant pathogen is described?
Question 31: A physician treats a patient with a severe systemic fungal infection using a polyene drug that binds to ergosterol in fungal cell membranes. This binding creates pores that allow essential cell contents to leak out, but the drug also carries significant risk of kidney damage. Which antifungal is described?
Question 32: A patient with a Candida bloodstream infection receives an antifungal drug that works by blocking the production of an essential structural component in the fungal cell wall. This mechanism is unique because human cells lack cell walls entirely, making the drug highly selective against fungi. Which drug class is described?
Question 33: A traveler returning from a tropical region presents with cyclic fevers and is diagnosed with malaria caused by Plasmodium falciparum. The physician prescribes a plant-derived drug used for centuries that works by generating reactive oxygen species inside the parasite. Which antiprotozoan drug is most likely prescribed?
Question 34: A physician treats a patient diagnosed with a tapeworm infection using a drug that disrupts the parasite's ability to maintain its protective outer covering, making it vulnerable to the host's digestive enzymes and immune defenses within the intestinal tract. Which antihelminthic drug category is most likely used?
Question 35: A dermatologist prescribes an oral antifungal medication for a patient with a persistent Candida infection. The drug works by inhibiting an enzyme needed to produce ergosterol, which weakens the fungal cell membrane and prevents the organism from maintaining its structural integrity. Which drug class is used?
Question 36: A patient diagnosed with a herpes simplex virus infection receives a drug that mimics a nucleoside building block. Once incorporated into the growing viral DNA chain, it halts further replication because the virus cannot add more nucleotides after this fake building block is inserted. Which drug is described?
Question 37: A patient presents with influenza symptoms within the first forty-eight hours of onset. The physician prescribes a drug that blocks viral particles from being released from infected host cells, limiting the spread of infection to neighboring cells throughout the respiratory tract. Which drug class is prescribed?
Question 38: A patient newly diagnosed with HIV begins antiretroviral therapy that includes a drug blocking the enzyme responsible for converting viral RNA into DNA inside the host cell. Without this conversion step, the virus cannot create the DNA copy needed to continue its replication cycle. Which drug class is used?
Question 39: An HIV specialist adds a drug to a patient's regimen that prevents newly assembled viral proteins from being cleaved into their functional forms. Without this processing step, the virus produces immature, nonfunctional particles that cannot infect new host cells effectively. Which drug class is added?
Question 40: A patient with treatment-resistant HIV receives a newer drug that works by preventing the virus from physically merging with host cell membranes during the very first step of cellular infection. By blocking entry entirely, no viral genetic material reaches the cell interior. Which drug class is described?
Don't Want to Study?
Save Time on Studies, Spend More with Family & Friends! Pay-After-you-Pass!
Get Exam Support